NCT06279572View on ClinicalTrials.gov

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Myeloid Leukemia
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Bone Marrow Aspirate

Undergo bone marrow aspirate

OTHER

Electronic Health Record Review

Medical records are reviewed

Trial Locations (3)

55905

NOT_YET_RECRUITING

Mayo Clinic in Rochester, Rochester

85259

NOT_YET_RECRUITING

Mayo Clinic in Arizona, Scottsdale

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06279572 - Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy | Biotech Hunter | Biotech Hunter